Variant report

Variant	rs10207791
Chromosome Location	chr2:182522862-182522863
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	GATA3	chr2:182522836-182522927	SH-SY5Y	brain:	n/a	n/a
2	GATA2	chr2:182522196-182523278	SH-SY5Y	brain:	n/a	chr2:182522468-182522481 chr2:182522821-182522832 chr2:182522318-182522328 chr2:182522307-182522324 chr2:182522318-182522325 chr2:182522316-182522326 chr2:182522316-182522325

Variant related genes	Relation type
CERKL	TF binding region

Extended variants
information (count: 30 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:25)

rs_ID	r²[population]
rs1000764	1.00[CHB][hapmap];1.00[JPT][hapmap]
rs10208667	0.88[AFR][1000 genomes];0.95[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs10930976	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap]
rs13398869	0.92[AMR][1000 genomes];0.91[EUR][1000 genomes]
rs13416231	0.92[AFR][1000 genomes];0.84[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs1528030	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.83[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2119517	0.92[AMR][1000 genomes];0.91[EUR][1000 genomes]
rs2583015	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];1.00[TSI][hapmap];0.87[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2583017	0.97[AFR][1000 genomes];0.84[AMR][1000 genomes];1.00[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2696344	0.84[AFR][1000 genomes]
rs2696345	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.82[AMR][1000 genomes];0.91[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs2696347	0.93[AFR][1000 genomes];0.84[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2696348	0.83[AFR][1000 genomes]
rs2696351	0.94[AFR][1000 genomes];0.84[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2696352	0.82[AFR][1000 genomes]
rs2950648	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.86[MEX][hapmap];1.00[TSI][hapmap];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs3856407	0.86[AFR][1000 genomes];0.95[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs3856408	0.81[AFR][1000 genomes];0.92[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs4666794	1.00[ASN][1000 genomes]
rs4666795	1.00[ASN][1000 genomes]
rs59476732	1.00[ASN][1000 genomes]
rs60472345	0.90[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs6718072	0.86[AFR][1000 genomes];0.95[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs6733263	0.81[AFR][1000 genomes];0.92[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs732483	0.81[AFR][1000 genomes];0.92[AMR][1000 genomes];0.95[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1005870	chr2:181968637-182921439	Enhancers Strong transcription Weak transcription Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
2	nsv536063	chr2:181968637-182921439	Enhancers Active TSS Weak transcription Strong transcription Bivalent/Poised TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
3	nsv1014910	chr2:182375267-182544114	Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	7 gene(s)	inside rSNPs	diseases
4	nsv536065	chr2:182375267-182544114	Enhancers Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	7 gene(s)	inside rSNPs	diseases
5	nsv834477	chr2:182438121-182593527	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats Bivalent/Poised TSS Flanking Active TSS Active TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	9 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:14 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:182522200-182523200	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr2:182522200-182526200	Enhancers	Duodenum Mucosa	Duodenum
3	chr2:182522400-182523400	Weak transcription	Spleen	Spleen
4	chr2:182522400-182523600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
5	chr2:182522400-182523600	Active TSS	Pancreatic Islets	Pancreatic Islet
6	chr2:182522400-182524800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
7	chr2:182522400-182526200	Enhancers	Fetal Intestine Large	intestine
8	chr2:182522400-182526800	Enhancers	Fetal Intestine Small	intestine
9	chr2:182522600-182523200	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
10	chr2:182522600-182523800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
11	chr2:182522600-182523800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
12	chr2:182522800-182523400	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr2:182522800-182523600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
14	chr2:182522800-182523800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links